By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Venus Concept Inc.

Venus Concept Inc. (VERO)

NASDAQ Currency in USD
$2.33
+$0.01
+0.22%
Last Update: 12 Sept 2025, 14:40
$4.32M
Market Cap
-0.08
P/E Ratio (TTM)
Forward Dividend Yield
$2.10 - $14.50
52 Week Range

VERO Stock Price Chart

Explore Venus Concept Inc. interactive price chart. Choose custom timeframes to analyze VERO price movements and trends.

VERO Company Profile

Discover essential business fundamentals and corporate details for Venus Concept Inc. (VERO) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

12 Oct 2017

Employees

292.00

CEO

Rajiv Kanishka Liyanaarchchie De Silva

Description

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.

VERO Financial Timeline

Browse a chronological timeline of Venus Concept Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 13 May 2026

Upcoming earnings on 13 Nov 2025

Revenue estimate is $14.48M.

Earnings released on 14 Aug 2025

EPS came in at -$8.03 surpassing the estimated -$9.72 by +17.39%, while revenue for the quarter reached $15.69M , beating expectations by +8.36%.

Earnings released on 15 May 2025

EPS came in at -$17.44 falling short of the estimated -$14.08 by -23.86%, while revenue for the quarter reached $13.64M , missing expectations by -6.50%.

Earnings released on 31 Mar 2025

EPS came in at -$11.23 falling short of the estimated -$10.01 by -12.19%, while revenue for the quarter reached $15.77M , beating expectations by +12.61%.

Stock split effective on 4 Mar 2025

Shares were split 1 : 11 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 13 Nov 2024

EPS came in at -$14.08 falling short of the estimated -$1.20 by -1.07K%, while revenue for the quarter reached $15.01M , missing expectations by -12.80%.

Earnings released on 13 Aug 2024

EPS came in at -$15.29 falling short of the estimated -$1.43 by -969.23%, while revenue for the quarter reached $16.58M , missing expectations by -2.34%.

Earnings released on 15 May 2024

EPS came in at -$18.48 falling short of the estimated -$1.53 by -1.11K%, while revenue for the quarter reached $17.48M , beating expectations by +2.94%.

Earnings released on 1 Apr 2024

EPS came in at -$22.11 falling short of the estimated -$1.18 by -1.77K%, while revenue for the quarter reached $18.13M , missing expectations by -19.23%.

Earnings released on 14 Nov 2023

EPS came in at -$18.04 falling short of the estimated -$1.51 by -1.09K%, while revenue for the quarter reached $17.62M , missing expectations by -21.53%.

Earnings released on 14 Aug 2023

EPS came in at -$14.85 falling short of the estimated -$1.54 by -864.29%, while revenue for the quarter reached $20.08M , missing expectations by -2.88%.

Earnings released on 15 May 2023

EPS came in at -$20.35 falling short of the estimated -$2.12 by -859.91%, while revenue for the quarter reached $20.53M , beating expectations by +10.50%.

Stock split effective on 12 May 2023

Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 27 Mar 2023

EPS came in at -$23.09 falling short of the estimated -$0.14 by -16.39K%, while revenue for the quarter reached $24.29M , beating expectations by +2.17%.

Earnings released on 10 Nov 2022

EPS came in at -$36.29 falling short of the estimated -$19.79 by -83.38%, while revenue for the quarter reached $21.54M , missing expectations by -2.69%.

Earnings released on 12 Aug 2022

EPS came in at -$26.39 falling short of the estimated -$13.19 by -100.08%, while revenue for the quarter reached $27.27M , missing expectations by -9.91%.

Earnings released on 12 May 2022

EPS came in at -$21.44 falling short of the estimated -$16.49 by -30.02%, while revenue for the quarter reached $26.41M , missing expectations by -2.28%.

Earnings released on 28 Mar 2022

EPS came in at -$13.19 surpassing the estimated -$19.79 by +33.35%, while revenue for the quarter reached $32.63M , beating expectations by +2.39%.

Earnings released on 12 Nov 2021

EPS came in at -$29.69 falling short of the estimated -$21.44 by -38.48%, while revenue for the quarter reached $24.56M , missing expectations by -22.81%.

Earnings released on 13 Aug 2021

EPS came in at -$6.60 surpassing the estimated -$23.09 by +71.42%, while revenue for the quarter reached $25.83M , meeting expectations.

Earnings released on 17 May 2021

EPS came in at -$28.04 falling short of the estimated -$24.74 by -13.34%, while revenue for the quarter reached $22.60M , beating expectations by +15.38%.

Earnings released on 29 Mar 2021

EPS came in at -$36.29 falling short of the estimated -$26.39 by -37.51%, while revenue for the quarter reached $25.83M .

Earnings released on 16 Nov 2020

EPS came in at -$29.69 surpassing the estimated -$39.58 by +24.99%, while revenue for the quarter reached $20.68M .

VERO Stock Performance

Access detailed VERO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run